Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence

Hodoglugil, Nuriye Nalan Sahin; Aslan, Dilek; Bertan, M

doi:10.1016/s0010-7824(00)00118-9

Cited by 43 publications

(18 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the presence of microorganisms associated with the studied contraceptive use, the findings corroborate studies [26,27] on the use of the pill and increased protection of women against any type of vaginal infection. However, the presence of copper intrauterine device is typically a promoter factor for bacterial [6,28].…”

Section: Discussionsupporting

confidence: 79%

Pap smears: Frequency of Gardnerella vaginalis, Candida spp., Trichomonas vaginalis and pill use or copper intrauterine device use

Alves

Nunes²,

Fakhouri³

et al. 2016

Int Arch Med

View full text Add to dashboard Cite

Objective: To verify the frequency of Gardnerella vaginalis, Candida sp. Trichomonas vaginalis in pap smears and the presence of these when using the copper intrauterine device or the oral contraceptive. Method:The analysis of 119,312 examinations of women seen by the public health system in the Northeast region of Brazil from the period from January 2006 to December 2010. The variables analyzed were age, frequency of microorganisms, contraceptive use, type of contraception adopted correlated with the presence of microorganisms. Results:The average age among the women was 33.4 ± 11.15 years.The most frequent microorganism, Gardnerella vaginalis, was found in 16,137 examinations, followed by Candida spp. in Trichomonas vaginalis and the 12,661 in 2023. The use of oral contraceptives was found in 21,792 women, and these, showed the presence of Gardnerella vaginalis in 1054, Candida spp. and Trichomonas vaginalis in 687 in 133 tests. Regarding the use of use of copper intrauterine device, used by 18,894 women, the presence of Gardnerella vaginalis was detected in 964, Candida spp. and Trichomonas vaginalis in 595 in 122 of the cases.

show abstract

Section: Discussionsupporting

confidence: 79%

Pap smears: Frequency of Gardnerella vaginalis, Candida spp., Trichomonas vaginalis and pill use or copper intrauterine device use

Alves

Nunes²,

Fakhouri³

et al. 2016

Int Arch Med

View full text Add to dashboard Cite

show abstract

“…IUD use has been associated with pelvic inflammatory disease, through contamination of the uterine cavity during insertion. 26 -28 Several authors have reported increases in genital infections and bacterial vaginosis, 14,29,30 but there is controversy over whether IUDs lower host resistance to infections. 31,32 Condoms were not protective, contradicting some reports mainly from developed countries, although lack of association has been also reported [reviewed in Ref.…”

Section: Discussionmentioning

confidence: 99%

Epidemiology of Genital Chlamydia trachomatis Infection Among Young Women in Costa Rica

Porras¹,

Safaeian²,

González³

et al. 2008

Sexually Transmitted Diseases

View full text Add to dashboard Cite

This is a high-prevalence population where we confirmed the strong link between Ct and sexual behavior of women and their partners. The establishment of a screening program in the age group included in this study should be considered. More studies are needed in developing countries to further investigate the role of intrauterine devices and the lack of protection by condoms, in addition to the interplay between Ct and other STIs, ectopy, inflammation, and epithelial abnormalities.

show abstract

“…Copper-containing intrauterine contraceptive devices (Cu-IUCD) are known to be associated with an increased risk of trichomoniasis, Actinomyces israelii and bacterial vaginosis, but not with candidosis [52,84,92,94] . In two older studies, however, Cu-IUCD users had a higher rate of Candida colonization than pill [94] or no-contraceptive users [91] .…”

Section: Hormones and Contraceptionmentioning

confidence: 99%

Management of Recurrent Vulvo-Vaginal Candidosis as a Chronic Illness

Donders

Bellen²,

Mendling

2010

Gynecol Obstet Invest

View full text Add to dashboard Cite

For sporadic acute Candida vaginitis, any oral or local antifungal therapy can be used. For women with recurrent vulvo-vaginal candidosis (RVC), on the other hand, such simple approaches are insufficient, regardless of the product chosen. Instead, RVC should be managed as any other chronic disease and requires long-term, prophylactic, suppressive antifungal treatment. A regimen using individualized, decreasing doses of oral fluconazole (the ReCiDiF regimen) was proven to be highly efficient and offered great comfort to the patients. During this regimen, it is crucial that patients are carefully examined by anamnestic, clinical, microscopic and culture-proven absence of Candida. If a relapse occurs, the medication is adjusted and efforts are taken to find a possible triggering factor for the reactivation of the infection. Care has to be taken not to accumulate ‘don’t do’s’, unless the efficiency of a measure has been proven, by trying to eliminate one risk factor at a time for 2 months. Known possible triggers to be kept in mind are (1) antibiotic use, (2) use of specific contraceptives, especially combined contraceptive pills, (3) disturbed glucose metabolism, (4) the use of personal hygienic products, and (5) tight clothing or plastic panty liners. In therapy-resistant cases, non-albicans infection must be ruled out, and alternative therapies should be tried. Boric acid is proven to be efficient in most of these resistant cases, but other non-azoles like amphotericin B, flucytosine, gentian violet, and even caspofungin may have to be tried. As a final remark it has to be said that many patients feel poorly understood and inefficiently managed by many care-givers, increasing their feelings of guilt and sexual inferiority. Therefore, attention has to be given to take the disease seriously, follow strict treatment regimens, and advise precisely and based on individual evidence concerning any possible risk factors for recurrence. In case of therapy-resistant vulvo-vaginitis, reconsider your diagnosis and/or consider referral to specialized therapists.

show abstract

Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence

Cited by 43 publications

References 7 publications

Pap smears: Frequency of Gardnerella vaginalis, Candida spp., Trichomonas vaginalis and pill use or copper intrauterine device use

Pap smears: Frequency of Gardnerella vaginalis, Candida spp., Trichomonas vaginalis and pill use or copper intrauterine device use

Epidemiology of Genital Chlamydia trachomatis Infection Among Young Women in Costa Rica

Management of Recurrent Vulvo-Vaginal Candidosis as a Chronic Illness

Contact Info

Product

Resources

About